ATXN3 and Parkinson disease: In these four patients, the proportions of parkinsonism (100% vs. 13.6%, p = .001) and psychiatric manifestations (50% vs. 6.8%, p = .049) were significantly higher compared to the other SCA3 patients without concomitant borderline increased repeats in SCA2 (Table 3).